Volume 22 Issue 2, February 2004
News in Brief
Immunomodulator CTLA4-Ig was set to be the miracle drug for organ transplantation a dozen years ago, but then faded from view. Now, with startling results in rheumatoid arthritis, costimulatory blockers are on a comeback. Ken Garber reports.
Permissive regulations in a few regions of the world are dictating where human embryonic stem (hES) cell research is taking place, but this could change as numerous countries are still formulating policy.
News & Views
A survey reveals that the way in which genetic sequences are claimed in granted patents are heterogeneous and imprecise, which may lead to questions regarding their validity.
New on the Market
Careers and Recruitment
As graduate programs in bioethics continue to grow and diversify, picking the right one requires careful planning for one's postgraduate career.